<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01610000_1</Organism_ID>
  <Organism>Influenza A virus</Organism>
  <Organism_Latin>Influenza A virus</Organism_Latin>
  <UniProt_ID>P63231</UniProt_ID>
  <Seq_Length>97</Seq_Length>
  <Molecule_Weight>11186</Molecule_Weight>
  <Function_Summary>Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry. After attaching to the cell surface, the virion enters the cell by endocytosis. Acidification of the endosome triggers M2 ion channel activity. The influx of protons into virion interior is believed to disrupt interactions between the viral ribonucleoprotein (RNP), matrix protein 1 (M1), and lipid bilayers, thereby freeing the viral genome from interaction with viral proteins and enabling RNA segments to migrate to the host cell nucleus, where influenza virus RNA transcription and replication occur. Also plays a role in viral proteins secretory pathway. Elevates the intravesicular pH of normally acidic compartments, such as trans-Golgi network, preventing newly formed hemagglutinin from premature switching to the fusion-active conformation (By similarity).</Function_Summary>
  <Pfam_ID>PF00599:Flu_M2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>2</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Influenza A M2 channel</Alias>
      <Alias>M2 ion channel</Alias>
      <Alias>Proton channel protein M2</Alias>
      <Alias>M2 proton channel</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Small transmembrane protein that homo-oligomerizes to form a viral ionic channel usually expressed in the viral envelope and host cell membranes. These channels affect membrane permeability to ions and play an important role in facilitating virus entry, assembly and release, as well as modulating the ionic homeostasis of host cells. Viral ionic channels are not necessarily required for the production of infectious virions, although their expression usually significantly increases growth. During influenza A virus entry for example, the M2 proton channel allows protons from the acidic endosome to enter the enveloped virion, initiating pH-dependent uncoating of the genome. In certain influenza A subtypes, M2 also equilibrates the intraluminal pH of the trans-Golgi network with the cytoplasm, preventing premature conformational changes in the viral fusion protein during budding.</Detail>
      <Keyword>Viral ionic channel</Keyword>
      <Ontology_ID>KW-1182</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of hydrogen ions from one side of a membrane to the other.</Detail>
      <Keyword>Hydrogen ion transmembrane transporter activity</Keyword>
      <Ontology_ID>GO:0015078</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.</Detail>
      <Keyword>Ion channel activity</Keyword>
      <Ontology_ID>GO:0005216</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Viral protein involved in the inhibition of host autophagy. Autophagy is a major intracellular pathway in the delivery of cytoplasmic material to lysosomes for degradation. It is also essential for the removal of pathogenic protein aggregates from the cell during infection. Several viruses including influenza and HIV-1 block autophagosome maturation by interacting with and inhibiting host Beclin-1, an essential protein playing a central role in autophagy.</Detail>
      <Keyword>Inhibition of host autophagy by virus</Keyword>
      <Ontology_ID>KW-1083</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Ion transport</Keyword>
      <Ontology_ID>GO:0006811</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of protons (hydrogen ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Proton transport</Keyword>
      <Ontology_ID>GO:0015992</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>82</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>89</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>64</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>93</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSLLTEVETPIRNEWGCRCNDSSDPLVVAASIIGILHLILWILDRLFFKCIYRFFEHGLKRGPSTEGVPESMREEYRKEQQSAVDADDSHFVSIELE</Protein_Seq>
    <DNA_Seq>AGCAAAAGCAGGTAGATATTGAAAGATGAGCCTTCTGACCGAGGTCGAAACGTATGTTCTCTCTATCGTTCCGTCAGGCCCCCTCAAAGCCGAGATCGCGCAGAGACTTGAAGATGTCTTTGCTGGAAAGAACACAGATCTTGAGGCTCTCATGGAATGGCTAAAGACAAGACCAATCCTGTCACCTCTGACTAAAGGGATTTTGGGATTTGTATTCACGCTCACCGTGCCCAGTGAGCGAGGACTGCAGCGTAGACGCTTTGTCCAAAATGCCCTCAATGGGAATGGGGATCCAAATAACATGGACAGAGCAGTTAAACTGTATAGAAAACTTAAGAGGGAGATAACATTCCATGGGGCCAAAGAAATAGCACTCAGTTATTCTGCTGGTGCACTTGCCAGTTGCATGGGCCTCATATACAACAGGATGGGGGCTGTGACCACTGAAGTGGCCTTTGGCCTGGTTTGTGCAACCTGTGAACAGATTGCTGACTCCCAGCACAGGTCTCATAGGCAAATGGTGGCAACAACCAATCCACTAATAAGACATGAGAACAGAATGGTTCTGGCCAGCACTACAGCTAAGGCTATGGAGCAAATGGCTGGATCAAGTGAGCAGGCAGCAGAGGCCATGGAGGTTGCTAGTCAGGCCAGGCAAATGGTGCAGGCAATGAGAGCCATTGGGACTCATCCTAGCTCCAGTGCTGGTCTAAAAGATGATCTTCTTGAAAATTTGCAGGCCTATCAGAAACGAATGGGGGTGCAGATGCAACGATTCAAGTGACCCTCTTGTTGTTGCTGCGAGTATCATTGGGATCTTGCACTTGATATTGTGGATTCTTGATCGTCTTTTTTTCAAATGCATCTATCGATTCTTTGAACACGGTCTGAAAAGAGGGCCTTCTACGGAAGGAGTACCTGAGTCTATGAGGGAAGAATATCGAAAGGAACAGCAGAGTGCTGTGGATGCTGACGACAGTCATTTTGTCAGCATAGAGCTGGAGTAAAAAACTACCTTGTTTCTACT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host apical cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>M</Gene_Name>
    <Genbank_ACCN>J02167</Genbank_ACCN>
    <Protein_ACCN>AAA43303</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/nuccore/324335?report=genbank</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>The Crystal structure of Transmembrane domain of M2 protein and Amantadine complex</PDB_Title>
      <PDB_ID>3C9J</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=3C9J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>amantadine</Ligand_Name>
      <PubMed_Title>Structural basis for the function and inhibition of an influenza virus proton channel.</PubMed_Title>
      <Author>Stouffer AL, et al.</Author>
      <Journal>(2008) Nature 451: 596-600</Journal>
      <PubMed_ID>18235504</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>S31N mutant of M2 proton channel</PDB_Title>
      <PDB_ID>2KIH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2KIH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mechanism of drug inhibition and drug resistance of influenza A M2 channel.</PubMed_Title>
      <Author>Pielak RM, et al.</Author>
      <Journal>(2009) Proc.Natl.Acad.Sci.USA 106: 7379-7384</Journal>
      <PubMed_ID>19383794</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Proton Channel M2 from Influenza A in complex with inhibitor rimantadine</PDB_Title>
      <PDB_ID>2RLF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2RLF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>rimantadine</Ligand_Name>
      <PubMed_Title>Structure and mechanism of the M2 proton channel of influenza A virus.</PubMed_Title>
      <Author>Schnell JR, et al.</Author>
      <Journal>(2008) Nature 451: 591-595</Journal>
      <PubMed_ID>18235503</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solid-state NMR structure of the M2 transmembrane peptide of the influenza A virus in DMPC lipid bilayers bound to deuterated amantadine</PDB_Title>
      <PDB_ID>2KQT</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2KQT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>amantadine</Ligand_Name>
      <PubMed_Title>Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers</PubMed_Title>
      <Author>Cady SD, et al.</Author>
      <Journal>(2010) Nature 463: 689-692</Journal>
      <PubMed_ID>20130653</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the transmembrane region of the M2 protein H+ channel by solid state NMR spectroscopy</PDB_Title>
      <PDB_ID>1MP6</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1MP6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the transmembrane region of the M2 protein H(+) channel.</PubMed_Title>
      <Author>Wang J, et al.</Author>
      <Journal>(2001) Protein Sci. 10: 2241-2250</Journal>
      <PubMed_ID>11604531</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,26,Leu;site,27,Val;site,31,Ser;site,34,Gly;site,38,Leu;site,40,Leu;site,41,Trp;site,42,Ile;site,43,Leu;site,44,Asp;site,45,Arg</Site_Detail>
      <Site_Reference>Pielak RM, et al. Proc.Natl.Acad.Sci U S A. 2009,106(18):7379-7384.</Site_Reference>
      <Site_Type>Open-Close</Site_Type>
      <PDB_ID>2KQT,3C9J,2RLF</PDB_ID>
      <PubMed_ID>19383794</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01610001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01610002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>